Interim report Q4/2022: A year that laid the foundation for growth

Significant events during the quarter Significant events after the quarter · On October 31, the journal · No significant events were reportedRespiratory Research published an in after the end of the quarter.-vitro study from the MedicalUniversity of Innsbruck which showsthat ColdZyme blocks the widespreadand highly transmissible omicronvariants BA.4 and BA.5 from adheringto and infecting human cells.According to the researchers whoconducted the study, this findingmeans the possibility that ColdZymecan be applied to prevent the spreadof SARS-CoV-2.